LSTA Stock Analysis: Buy, Sell, or Hold?
LSTA - Lisata Therapeutics, Inc. Common Stock
$4.63
-0.01 (-0.22%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When LSTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: LSTA is 39.0% above fair value ($3.33). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: LSTA is 39.0% above fair value ($3.33). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: LSTA is currently trading at $4.63, which is considered extended relative to its 30-day fair value range of $1.59 to $3.33.
Technical Outlook: Technically, LSTA is showing sideways momentum. Immediate support is located at $2.05, while resistance sits at $4.89.
Market Sentiment: LSTA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.33 (+144.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LSTA is showing sideways momentum. Immediate support is located at $2.05, while resistance sits at $4.89.
Market Sentiment: LSTA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.33 (+144.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.59 -
$3.33
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
LSTA is technically overbought (RSI 90). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+39.0% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 144.3% below Wall St target ($11.33)
- WARNING: Recommendation downgraded due to 39.0% overvaluation
Fair Price Analysis
30-Day Fair Range
$1.59 -
$3.33
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$2.05
Resistance Level
$4.89
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-4.53
Wall Street Target
$11.33
(+144.3%)
Last updated: January 31, 2026 5:49 AM ET
Data refreshes hourly during market hours. Next update: 6:49 AM
Data refreshes hourly during market hours. Next update: 6:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LSTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
Advanced LSTA Option Strategies
Professional options setups generated by AI based on today's LSTA price and gamma walls.
